Showing results (31-40 of 100) with videos related to
Sort By:
Pageof 10
JCI Insight|August 16, 2016
ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarctionOscar Bartulos, Zhen Wu Zhuang, Yan Huang, et al.Translational Cancer Research|February 4, 2022
Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective studyLei Lei, Wen-Xian Wang, You-Cai Zhu, et al.Thoracic Cancer|August 29, 2017
Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature reviewChun-Wei Xu, Wen-Xian Wang, Rong-Fang Huang, et al.Radiation Oncology (London, England)|July 19, 2022
Clinical significance of tumor-infiltrating lymphocytes investigated using routine H&E slides in small cell lung cancerGuangrun Zhou, Jifang Zheng, Zhiwei Chen, et al.Thoracic Cancer|June 8, 2017
Comparison of the c-MET gene amplification between primary tumor and metastatic lymph nodes in non-small cell lung cancerChun-Wei Xu, Wen-Xian Wang, Mei-Juan Wu, et al.Journal of Cancer|February 3, 2021
A real-world study in advanced non-small cell lung cancer with de novo brain metastasisLei Lei, Wen-Xian Wang, Dong Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 29, 2017
Comparison of 22C3 PD-L1 Expression between Surgically Resected Specimens and Paired Tissue Microarrays in Non-Small Cell Lung CancerChao Li, Cheng Huang, Tony S Mok, et al.Translational Oncology|June 4, 2020
Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non-Small Cell Lung Cancer and Response to EGFR TKIsChun-Wei Xu, Lei Lei, Wen-Xian Wang, et al.Hepatology International|December 1, 2023
The TAE score predicts prognosis of unresectable HCC patients treated with TACE plus lenvatinib with PD-1 inhibitorsZhen-Xin Zeng, Jia-Yi Wu, Jun-Yi Wu, et al.European Journal of Cancer (Oxford, England : 1990)|July 2, 2023
Efficacy and safety of KN046, a novel bispecific antibody against PD-L1 and CTLA-4, in patients with non-small cell lung cancer who failed platinum-based chemotherapy: a phase II studyAnwen Xiong, Wei Li, Xingya Li, et al.Pageof 10